Dr. Don Stevens, MD
Claim this profileNorton Cancer Institute
Studies Non-Hodgkin's Lymphoma
Studies Lymphoma
26 reported clinical trials
46 drugs studied
Area of expertise
1Non-Hodgkin's Lymphoma
CD20 positive
CD20
WM
2Lymphoma
CD20
WM
UGT1A1 positive
Affiliated Hospitals
Clinical Trials Don Stevens, MD is currently running
Venetoclax, Azacitidine, and Cusatuzumab
for Acute Myeloid Leukemia
The goal of this clinical trial is to learn if participants treated with the experimental drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to venetoclax and azacitidine. Venetoclax and azacitidine are drugs commonly used to treat AML in patients that are unable to receive chemotherapy to treat AML. The main question the clinical trial aims to answer is does cusatuzumab added to venetoclax and azacitidine prolong the length of time participants live compared to venetoclax and azacitidine?
Recruiting1 award Phase 21 criteria
ACE1831 Cell Therapy
for B-Cell Lymphoma
This trial is testing ACE1831, a cell therapy made from healthy donors' immune cells, in patients with CD20-expressing Non-Hodgkin lymphoma. The therapy aims to use special immune cells to target and kill cancer cells with the CD20 marker. Rituximab, a monoclonal antibody targeting CD20, has been widely used in treating B-cell malignancies such as non-Hodgkin's lymphoma.
Recruiting1 award Phase 1
More about Don Stevens, MD
Clinical Trial Related3 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Don Stevens, MD has experience with
- Dexamethasone
- Rituximab
- AgenT-797
- AVM0703
- Supra-Pharmacologic Dexamethasone Sodium Phosphate
- Cisplatin
Breakdown of trials Don Stevens, MD has run
Non-Hodgkin's Lymphoma
Lymphoma
Leukemia
Follicular Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Don Stevens, MD specialize in?
Don Stevens, MD focuses on Non-Hodgkin's Lymphoma and Lymphoma. In particular, much of their work with Non-Hodgkin's Lymphoma has involved CD20 positive patients, or patients who are CD20.
Is Don Stevens, MD currently recruiting for clinical trials?
Yes, Don Stevens, MD is currently recruiting for 9 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Don Stevens, MD has studied deeply?
Yes, Don Stevens, MD has studied treatments such as Dexamethasone, Rituximab, agenT-797.
What is the best way to schedule an appointment with Don Stevens, MD?
Apply for one of the trials that Don Stevens, MD is conducting.
What is the office address of Don Stevens, MD?
The office of Don Stevens, MD is located at: Norton Cancer Institute, Louisville, Kentucky 40207 United States. This is the address for their practice at the Norton Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.